Cheryl A Stoddart

Title: Cheryl A Stoddart: Innovator in CD47 Targeted Therapies

Introduction

Cheryl A Stoddart is a prominent inventor based in Christchurch, New Zealand. She has made significant contributions to the field of infectious disease treatment through her innovative research and patent work. Her dedication to advancing medical science has led to the development of novel therapeutic methods.

Latest Patents

Cheryl A Stoddart holds a patent for "CD47 targeted therapies for the treatment of infectious disease." This patent outlines methods for treating subjects with intracellular pathogen infections by administering agents that reduce the binding of CD47 on infected cells to SIRPα on host phagocytic cells. This approach is designed to enhance the phagocytosis of infected cells, providing a promising avenue for treatment.

Career Highlights

Throughout her career, Cheryl has worked with esteemed institutions such as Leland Stanford Junior University and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Cheryl has collaborated with notable colleagues, including Kipp Andrew Weiskopf and Kim J Hasenkrug. These partnerships have further enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Cheryl A Stoddart's innovative contributions to the field of infectious disease treatment through her patent on CD47 targeted therapies exemplify her commitment to advancing medical science. Her collaborations and career achievements highlight her role as a leading inventor in this important area of research.